Navigation Links
Ventas Enters Agreement to Sell Common Stock
Date:1/29/2008

Gross Proceeds Expected to Be Approximately $168.6 Million

LOUISVILLE, Ky., Jan. 29 /PRNewswire-FirstCall/ -- Ventas, Inc. (NYSE: VTR) ("Ventas" or the "Company") announced today that it has agreed to sell 3,900,000 shares of its common stock to UBS Investment Bank, as sole underwriter, in an underwritten public offering. The Company has also granted UBS Investment Bank a 30-day option to purchase up to an additional 585,000 shares of common stock to cover overallotments, if any. Gross proceeds from the offering (before deducting the underwriting discount and expenses) are expected to be approximately $168.6 million (or $193.9 million if the underwriter's overallotment option is exercised in full). The Company will use the net proceeds to repay indebtedness outstanding under its revolving credit facility and for other general corporate purposes, including acquisitions. Completion of the offering is subject to customary closing conditions.

The shares of common stock are being offered under the Company's existing shelf registration statement, which became automatically effective upon filing with the Securities and Exchange Commission. A prospectus supplement and accompanying prospectus describing the terms of the offering will be filed with the Securities and Exchange Commission. When available, copies of the prospectus supplement and the accompanying prospectus may be obtained from: UBS Investment Bank, 299 Park Avenue, New York, New York 10171, Attention: Prospectus Department, or by phone at 888-827-7275.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sales of these securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of such jurisdiction.

Ventas, Inc. is a leading healthcare real estate investment trust. Its diverse portfolio of properties located in 43
'/>"/>

SOURCE Ventas, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Ventas Grants Stock Awards to Promote Long-Term Retention and Reward Performance
2. Ventas Declares Regular Quarterly Dividend of $0.475 Per Share
3. Ventas Appoints Brush SVP - Senior Housing Development and Operations
4. Ventas Announces 2007 Third Quarter Earnings Release Date and Conference Call
5. Ventas Board Names Ronald G. Geary Audit Committee Chair; Appoints Douglas Crocker II to Fill Vacancy on Audit Committee
6. Ventas Declares Regular Quarterly Dividend of $0.475 Per Share
7. Inverness Medical Innovations Enters Into a Definitive Agreement to Acquire Matria Healthcare, Inc.
8. Excessive overtriage in US trauma centers overwhelming system resources, delaying patient care
9. Labopharm enters into licensing and distribution agreement for once-daily tramadol in Australia with iNova
10. New Company Enters Companion Animal Veterinary Medicine Channel
11. Millennium Enters Into $600,000 Product Development Agreement to Fund Product Development for the $20,000,000 Purchase Agreement with Provider Services, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/20/2014)... Unveiled at the Sept. 18 board meeting, The ... member hospital ROI on membership dues at 12.5. In other ... $12.50 in value to member hospitals. The calculation used to ... Dues. , “This is the first time we’ve actually ... the methodology is really sound,” said Bill Ryan , ...
(Date:10/20/2014)... Houston plastic surgeon Dr. Christopher ... of his innovative True Form Tummy Tuck® ... and faculty at The University of Texas Medical ... once a medical student. Patronella, who is a founding ... surgery practices in Texas, The Aesthetic Center for ...
(Date:10/19/2014)... The leading review website, Top10BestSEOHosting.com, ... and GreenGeeks are the best Dedicated Server Hosting ... who want to buy high quality hosting and ... IT manager of Top10BestSEOHosting.com says, “We believe that ... for everyone. A lot of the global clients ...
(Date:10/19/2014)... October 20, 2014 This report ... Partial Seizure, complete with comparative analysis at various ... action (MoA), route of administration (RoA) and molecule ... and press releases. It also reviews key players ... and special features on late-stage and discontinued projects. ...
(Date:10/19/2014)... Recently, Fancyflyingfox.com, an innovative company that provides many ... latest designs of 2014 mother of the bride ... are offered with big discounts, up to 70% off. ... can enjoy this special offer. , Owing to ... become one of the leading brands in the global ...
Breaking Medicine News(10 mins):Health News:Scorecard Estimates Hospital ROI at $12.50 for every $1 Spent on Dues 2Health News:Scorecard Estimates Hospital ROI at $12.50 for every $1 Spent on Dues 3Health News:Scorecard Estimates Hospital ROI at $12.50 for every $1 Spent on Dues 4Health News:Plastic Surgeon Patronella Presents Artistically-Inspired Tummy Tuck Method to Future Generation of Plastic Surgeons in Texas 2Health News:Top10BestSEOHosting.com Considers iPage And GreenGeeks As The Best Dedicated Server Hosting Suppliers 2Health News:Partial Seizure Therapeutic Pipeline Market Review H2 2014 in a New Report Available at RnRMarketResearch.com 2Health News:Partial Seizure Therapeutic Pipeline Market Review H2 2014 in a New Report Available at RnRMarketResearch.com 3Health News:Partial Seizure Therapeutic Pipeline Market Review H2 2014 in a New Report Available at RnRMarketResearch.com 4Health News:Fancyflyingfox.com Updates Its Website With New Mother Of The Bride Dresses For 2014 2
... Citing persistent noncompliance and numerous performance deficiencies, the Department of ... a five-year, $75 million contract with the University of Texas ... Veterans, Illnesses (GWVI). , , "Research into ... for VA," said Dr. Gerald M. Cross, VA,s Acting Under ...
... , , , ... WASHINGTON, Aug. 26 Last night in northern Virginia, Representative James ... health care that was attended by thousands of people. Anti-abortion extremist ... the event that he would be there to disrupt it by ...
... Breast Cancer Metastasis Dr. Amanda Harvey and colleagues ... a role in breast cancer progression and dissemination. Their ... the American Journal of Pathology . ... breast cancer patients. Non-metastatic breast cancer cells rely on ...
... Singapore are reporting development of a new electronic sensor that ... alternative than tests now used to detect DNA. Such ... purposes. The new lab-on-a-chip test could lead to wider, more ... is scheduled for the Sept. 2 issue of the ...
... , Large variations exist in peoples, ability to eliminate arsenic ... existing standards for evaluating the human health risks from the ... more than 90 percent of the arsenic consumed in the ... have harmful effects. The research, based on the first application ...
... , PALM BEACH GARDENS, Fla., Aug. 26 The only effective ... from Chinese Drywall is now available. The RISS System(TM) removes the ... RISS system is so unique that it is in Patent Pending status with ... The RISS System(TM) : ( www.RISS s y s ...
Cached Medicine News:Health News:VA Continues Gulf War Research, Cancels Contract with UTSW Medical Center 2Health News:Randall Terry Removed By Police From Howard Dean Health Care Town Hall Meeting 2Health News:Tips from the American Journal of Pathology 2Health News:Tips from the American Journal of Pathology 3Health News:Tips from the American Journal of Pathology 4Health News:Tips from the American Journal of Pathology 5Health News:Proven Solution for Chinese Drywall is Now Available 2
(Date:10/19/2014)... October 19, 2014 Große ... Das Problem dabei ist, dass große Pharmafirmen ... Kompetenz zu teilen. Es war deshalb ... wir uns umso mehr, dass es uns gelungen ... bei Kühlketten aufzuschreiben - mit einem Vorbehalt - ...
(Date:10/17/2014)... , Oct. 17, 2014  Training market ... a critical success factor in today,s highly competitive ... market research organizations that effectively and efficiently produce ... or service area. Effective training ... and earn recognition from internal clients by developing ...
(Date:10/17/2014)... , Oct. 17, 2014 UBM Medica US ... a leading online community and information resource for neurologists and ... and Alzheimer disease , with discussions of the ... 1 million Americans have Parkinson disease , more than ... or Lou Gehrig disease. Diagnosis can be difficult ...
Breaking Medicine Technology:Vergleichsbericht zu Pharma-Kühlketten und CRT 2Effective Training Programs for Market Research Groups can Boost Overall Organizational Success 2Neurology Times Features Coverage of Parkinson and Alzheimer Disease 2Neurology Times Features Coverage of Parkinson and Alzheimer Disease 3
... An optimized PARI eFlow,platform nebulizer will be ... trial that has begun enrolling patients. ALN-RSV01 is ... respiratory syncytial virus,(RSV) infection, the leading cause of ... in immune-compromised adults. RSV currently does,not have a ...
... SGP ), a leader in advancing the ... infection, announced today that final,results of the IDEAL ... studies,with PEGINTRON(TM) (peginterferon alfa-2b) and REBETOL(R) (ribavirin, USP),combination ... for the,Study of the Liver (EASL) 43rd annual ...
Cached Medicine Technology:PARI's eFlow Delivers Alnylam RNAi Therapeutic in Phase II Study 2Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Data Presentations at European Association for the Study of the Liver (EASL) Annual Meeting 2Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Data Presentations at European Association for the Study of the Liver (EASL) Annual Meeting 3Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Data Presentations at European Association for the Study of the Liver (EASL) Annual Meeting 4Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Data Presentations at European Association for the Study of the Liver (EASL) Annual Meeting 5Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Data Presentations at European Association for the Study of the Liver (EASL) Annual Meeting 6Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Data Presentations at European Association for the Study of the Liver (EASL) Annual Meeting 7Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Data Presentations at European Association for the Study of the Liver (EASL) Annual Meeting 8Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Data Presentations at European Association for the Study of the Liver (EASL) Annual Meeting 9
... LactoSorb copolymer maintains almost all its mechanical ... mass loss in 915 months. Blunt thread ... Seventeen sizes to maximize surgeons options. ... entire screw to help prevent the screw ...
... The Asnis III™ Cannulated Screw System ... 2 and TCS Systems and combined them ... cannulated screws in both titanium and stainless ... Screw System is designed to optimize surgical ...
The properties of titanium alloy have been combined with a uniquely designed reverse radial tapping flute to produce a state-of-the-art fracture fixation system....
... The VersaNail System is a complete system ... to use with TTC fusion surgery. The ... specialists and integrates clinical research and engineering ... Because every patient is different, and because ...
Medicine Products: